Abstract | BACKGROUND: The purpose of the research is to investigate the roles of Jak-STAT3 signaling pathway in bufalin-induced apoptosis in colon cancer SW620 cells. METHODS: The inhibitory effects of bufalin on cell proliferation were determined by MTT (Methyl thiazolyltetrazolium) assay. The morphological changes of cells were measured by Wright-Giemsa staining. The cell cycle arrest and apoptosis were tested by flow cytometry analysis. Western Blot was used to determine the protein expression of the apoptosis inhibitors livin and caspase-3, the apoptosis-related proteins Bax and Bcl-2, as well as the key protein kinases in the Jak-stat3 signaling pathway, stat3 and p-stat3. RESULTS: (1) Bufalin inhibited the proliferation of SW620 cells. IC50 at 24 h, 48 h and 72 h were 76.72 ± 6.21 nmol/L, 34.05 ± 4.21 nmol/L and 16.7 ± 6.37 nmol/L. (2) Bufalin induced SW620 cell cycle arrest and apoptosis, indicated by the appearance of apoptotic bodies; (3) The results from flow cytometry demonstrated that there was cell cycle G2/M phase arrest in 20 nmol/L bufalin treatment group (36.29 ± 2.11% vs 18.39 ± 1.74%, P<0.01); there was a sub-diploid apoptosis peak in 80 nmol/L bufalin treatment group (19.69 ± 1.63% vs 0.99 ± 0.23%, P <0.01). The apoptosis rate was 34.63 ± 2.57% (vs 19.69 ± 1.63%, P = 0.002) in JAK kinase inhibitor AG490 plus bufalin treatment group. (4) During the process of bufalin-induced apoptosis in SW620 cells, transient activation of p-stat3 inhibited the activation of stat3, up-regulated Bax expression, down-regulated livin and Bcl-2 expression (P<0.01), and activated caspase-3. Inhibition of Jak-stat3 signaling pathway by pre-treatment with AG490 significantly enhanced the bufalin-induced apoptosis (P<0.01), further up-regulated Bax protein expression, down-regulated livin and Bcl-2 protein expression and enhanced caspase-3 activation. CONCLUSIONS:
Bufalin not only inhibited the growth of colon cancer SW620 cells, but also induced apoptosis of SW620 cells. Activation of caspase-3, up-regulation of Bax, down-regulation of livin and Bcl-2, as well as inhibition of Jak-stat3 signaling pathway might be the important mechanisms for the bufalin-induced apoptosis.
|
Authors | Zhitu Zhu, Enze Li, Yangyang Liu, Yu Gao, Hongzhi Sun, Guangyou Ma, Zhenghua Wang, Xiaomei Liu, Qingjun Wang, Xiujuan Qu, Yunpeng Liu, Yunlong Yu |
Journal | World journal of surgical oncology
(World J Surg Oncol)
Vol. 10
Pg. 228
(Oct 30 2012)
ISSN: 1477-7819 [Electronic] England |
PMID | 23110625
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Bufanolides
- Enzyme Inhibitors
- STAT3 Transcription Factor
- STAT3 protein, human
- Tyrphostins
- alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
- JAK1 protein, human
- Janus Kinase 1
- bufalin
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Antineoplastic Combined Chemotherapy Protocols
- Apoptosis
(drug effects)
- Blotting, Western
- Bufanolides
(pharmacology)
- Cell Cycle
(drug effects)
- Cell Proliferation
(drug effects)
- Colonic Neoplasms
(drug therapy, metabolism, pathology)
- Enzyme Inhibitors
(pharmacology)
- Humans
- Janus Kinase 1
(antagonists & inhibitors, metabolism)
- Mitotic Index
- STAT3 Transcription Factor
(antagonists & inhibitors, metabolism)
- Tumor Cells, Cultured
- Tyrphostins
(pharmacology)
|